Conclusion Of Non-exclusive Discount Agreements According To 130a Para. 8 Sgb V On Medicinal Products (open-house Procedure) [Tender documents : T487403780]

Contract notice: conclusion of non-exclusive discount agreements according to 130a para. 8 sgb v on medicinal products (open-house procedure) This ohv is not subject to public procurement law and has already been eu 2023/s 079-237358 published in the supplement to the official gazette of the eu (fir...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MENA Report
Format: Newsletter
Sprache:Englisch
Veröffentlicht: Camden Disco Digital Media, Inc 06.06.2023
Schlagworte:
ISSN:2219-0112
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Contract notice: conclusion of non-exclusive discount agreements according to 130a para. 8 sgb v on medicinal products (open-house procedure) This ohv is not subject to public procurement law and has already been eu 2023/s 079-237358 published in the supplement to the official gazette of the eu (first publication). the customer has expanded the procurement requirements for this procedure and hereby announces this in accordance with its announcement under section ii.2.4) of the initial announcement and section a.I.4.1 of the conditions of participation (follow-up announcement). aok bw intends to enter into non-exclusive discount agreements with all suitable pharmaceutical companies in accordance with section 130a para. 8 sgb v on medicines with the active ingredients named in appendix 3 to the conditions of participation. the contract period begins for the active substances/combinations of active substances according to para. ii.2.4) of the first publication no earlier than 07/01/2023 and is a maximum of 24 months. the contract period begins for the active substances/combinations of active substances according to para. ii.2.4) of this follow-up notice no earlier than 08/01/2023 and is a maximum of 23 months.The procurement requirements of ohv 2023 include all medicinal products with the active ingredients specified in annex 3 to the conditions of participation (so-called list of active ingredients and deadlines). the aok baden-wuerttemberg (aok) has the procurement requirements of the already announced abl. eu 2023/s 079-237358 announced open-house procedure extended in such a way that also for the medicinal products with the following combination of active ingredients within the framework of this open-house procedure agreements according to 130a para. 8 sgbv are to be closed: beclometasone dipropionate + formoterol hemifumarate-1-water (serial no. 10 of annex 3 to the conditions of participation, as of 31.05.2023). annex 3 to the conditions of participation was supplemented accordingly and is subordinate to the interested companies free registration - together with the other procedural documents - on the award platform (see item i.3) of this announcement). the aok reserves the right to expand the procurement requirements of this open-house procedure in the course of the further procedure with further active ingredients. the conditions of participation (section a.I.4.1) contain more detailed information on a possible expansion of the procurement requirements. combination of active ingredients will be closed with effect from august 1st, 2023 at the earliest. all discount contracts concluded as part of this open-house procedure end on 06/30/2025. for the earliest possible start of discount contracts with the above combination of active ingredients on august 1st, 2023, interested companies must submit a complete offer according to the participation documents exclusively in electronic form via the communication area of the award platform by june Major organization : AOK BADEN-WRTTEMBERG Address : Presselstrae 19 Country :Germany Email : ohv@bw.aok.de Url : www.aok.de/bw Tender notice number : 334083-2023 Notice type : T489360570.html © 2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info).
AbstractList Contract notice: conclusion of non-exclusive discount agreements according to 130a para. 8 sgb v on medicinal products (open-house procedure) This ohv is not subject to public procurement law and has already been eu 2023/s 079-237358 published in the supplement to the official gazette of the eu (first publication). the customer has expanded the procurement requirements for this procedure and hereby announces this in accordance with its announcement under section ii.2.4) of the initial announcement and section a.I.4.1 of the conditions of participation (follow-up announcement). aok bw intends to enter into non-exclusive discount agreements with all suitable pharmaceutical companies in accordance with section 130a para. 8 sgb v on medicines with the active ingredients named in appendix 3 to the conditions of participation. the contract period begins for the active substances/combinations of active substances according to para. ii.2.4) of the first publication no earlier than 07/01/2023 and is a maximum of 24 months. the contract period begins for the active substances/combinations of active substances according to para. ii.2.4) of this follow-up notice no earlier than 08/01/2023 and is a maximum of 23 months.The procurement requirements of ohv 2023 include all medicinal products with the active ingredients specified in annex 3 to the conditions of participation (so-called list of active ingredients and deadlines). the aok baden-wuerttemberg (aok) has the procurement requirements of the already announced abl. eu 2023/s 079-237358 announced open-house procedure extended in such a way that also for the medicinal products with the following combination of active ingredients within the framework of this open-house procedure agreements according to 130a para. 8 sgbv are to be closed: beclometasone dipropionate + formoterol hemifumarate-1-water (serial no. 10 of annex 3 to the conditions of participation, as of 31.05.2023). annex 3 to the conditions of participation was supplemented accordingly and is subordinate to the interested companies free registration - together with the other procedural documents - on the award platform (see item i.3) of this announcement). the aok reserves the right to expand the procurement requirements of this open-house procedure in the course of the further procedure with further active ingredients. the conditions of participation (section a.I.4.1) contain more detailed information on a possible expansion of the procurement requirements. combination of active ingredients will be closed with effect from august 1st, 2023 at the earliest. all discount contracts concluded as part of this open-house procedure end on 06/30/2025. for the earliest possible start of discount contracts with the above combination of active ingredients on august 1st, 2023, interested companies must submit a complete offer according to the participation documents exclusively in electronic form via the communication area of the award platform by june Major organization : AOK BADEN-WRTTEMBERG Address : Presselstrae 19 Country :Germany Email : ohv@bw.aok.de Url : www.aok.de/bw Tender notice number : 334083-2023 Notice type : T489360570.html © 2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info).
BookMark eNqFjMtKAzEYRoMoWGvf4V-40MVIbjNJ3ZV6hWoLDm5ESib5pw7UpCaN-jA-rK117-qDw_nOEdn3weMe6XHOhgVljB-SQUpdQylVeqh02SPf4-DtMqcueJi28BB8gV-_4APhsks2ZL-G0SIivqFfJxhZG6Lr_ALqAExQAzMTzTloeFw08ARTD_foOtt5s4RZDC7bzes0rNAXryEn3EKLLkc8g-cavcMILti8y19ALbWSVChNX47JQWuWCQd_2yf19VU9vi0m05u78WhSrEqtCyZbaWWrjJC0omUjK1VqxlEYKbARximj262klStVox1S69RGVc5IWVnRJye77CqG94xpPf_sIraILs255lxXVUX1PxqVTLGh5OIH0zpwTQ
ContentType Newsletter
Copyright 2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info).
Copyright_xml – notice: 2022 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. (Syndigate.info).
DBID 0TT
0U~
3V.
7RQ
7WY
7XB
87Y
8FK
8FL
8G5
ABUWG
AFKRA
AZQEC
BENPR
BEZIV
CCPQU
DWQXO
FRNLG
GNUQQ
GUQSH
K60
K6~
KB~
L.-
M0B
M2O
MBDVC
PHGZM
PHGZT
PKEHL
PQBIZ
PQBZA
PQEST
PQQKQ
PQUKI
Q9U
U9A
DatabaseName News PRO
Global News & ABI/Inform Professional
ProQuest Central (Corporate)
Career & Technical Education Database (ProQuest)
ABI/INFORM Collection
ProQuest Central (purchase pre-March 2016)
ABI/INFORM Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
ABI/INFORM Collection (Alumni)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
Business Premium Collection
ProQuest One Community College
ProQuest Central
Business Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Business Collection (Alumni Edition)
ProQuest Business Collection
ProQuest Newsstand Professional
ABI/INFORM Professional Advanced
ABI/INFORM Dateline
Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest One Business
ProQuest One Business (Alumni)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
DatabaseTitle ProQuest Business Collection (Alumni Edition)
ProQuest One Business
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
News PRO
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ABI/INFORM Complete
ProQuest Central
Global News & ABI/Inform Professional
ABI/INFORM Dateline (Alumni Edition)
ABI/INFORM Professional Advanced
ProQuest Central Korea
ABI/INFORM Dateline
ProQuest Research Library
ProQuest Central (New)
ProQuest Newsstand Professional
ABI/INFORM Complete (Alumni Edition)
Career and Technical Education (Alumni Edition)
Business Premium Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Business Collection
ProQuest Career and Technical Education
ProQuest One Academic UKI Edition
ProQuest One Business (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Business Premium Collection (Alumni)
DatabaseTitleList ProQuest Business Collection (Alumni Edition)
Database_xml – sequence: 1
  dbid: 7RQ
  name: Career & Technical Education Database
  url: https://search.proquest.com/career
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 2219-0112
Genre News
GroupedDBID 0TT
0U~
3V.
7RQ
7WY
7XB
8FK
8FL
8G5
ABUWG
AFKRA
AZQEC
BENPR
BEZIV
CCPQU
DWQXO
FRNLG
GNUQQ
GUQSH
K60
K6~
KB~
L.-
M0B
M2O
MBDVC
PHGZM
PHGZT
PKEHL
PQBIZ
PQBZA
PQEST
PQQKQ
PQUKI
Q9U
U9A
ID FETCH-LOGICAL-p588-14f4c4f7a340605b4675812e3a43eb3ad7a8f14f487d57b8de0cd70607da446c3
IEDL.DBID BENPR
IngestDate Tue May 13 22:37:31 EDT 2025
Thu May 15 10:45:47 EDT 2025
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p588-14f4c4f7a340605b4675812e3a43eb3ad7a8f14f487d57b8de0cd70607da446c3
NewspaperSection Pharmaceuticals
PQID 2804171942
PQPubID 27517
ParticipantIDs proquest_wirefeeds_2822866608
proquest_wirefeeds_2804171942
PublicationCentury 2000
PublicationDate 20230606
PublicationDateYYYYMMDD 2023-06-06
PublicationDate_xml – month: 06
  year: 2023
  text: 20230606
  day: 06
PublicationDecade 2020
PublicationPlace Camden
PublicationPlace_xml – name: Camden
PublicationTitle MENA Report
PublicationYear 2023
Publisher Disco Digital Media, Inc
Publisher_xml – name: Disco Digital Media, Inc
SSID ssib000789785
Score 1.6243258
Snippet Contract notice: conclusion of non-exclusive discount agreements according to 130a para. 8 sgb v on medicinal products (open-house procedure) This ohv is not...
SourceID proquest
SourceType Aggregation Database
SubjectTerms Agreements
Government purchasing
Pharmaceutical industry
Title Conclusion Of Non-exclusive Discount Agreements According To 130a Para. 8 Sgb V On Medicinal Products (open-house Procedure) [Tender documents : T487403780]
URI https://www.proquest.com/docview/2804171942
https://www.proquest.com/docview/2822866608
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwELXKwoFTqQBRWtAceoCD2yT21l4uiKWgHmB3S6MCQhUaxzZFWiU0Iav-mP7YerxBrYQQh14s5dORk8zTG3veY-ydsQPnpUAuJTouCyO5kRo5CvQuvBRMRSwUPlGjkb64GEy6hFvTLat8iIkxUNuqoBz5h4yEclSg3Nn-3U9OrlE0u9pZaCywRVIqlz22ODwaTc7-BcBAk_qPAm1Ej-OX_9vvClumWDSNlTev2AtXrrLfh1VZTFvKdcHYw6gqufsVd8wcfLptogcEHAQ2HfN_DZAtRE1ABXkFAVIQJljje9Dw9cbANxiXcDqfZ8cpTOY6sA3skLsW_1G1jYNYU2Db2u3CVR4d6CA8fju__R7kknz3hNLJ9zWWHx_lh59557TA7_rhT0mll4X0CkWA96RvJLGINHMCpQhkG61C7ekkrWxfGW1dUliS3VEWA50sxDrrlVXpNhgIlWn0xthUW4leDFLtlUGZJtapRNrXbOthmK9JjNkHjG6u_w7yU8ezTAeilejNZ65_w5bJED4u5vr4lvXu69ZtsaVidn_b1NtsQZ19ofb8crv7VMLWaTKkNhv_AalSzQQ
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3fSxwxEA7WFuqTllasvzoPLbQPsbubnMkJRUQriud50KW1SDkmm0SFY1d3Xav_i_-C_2MzuR4tlNInH_q6PwKbGebLNzszH2Ovje06LwVyKdFxWRjJjdTIUaB3wSiYitgo3FP9vj4-7g6m2P2kF4bKKicxMQZqWxWUI3-f0aAcFSh3tnlxyUk1iv6uTiQ0xm5x4G6_B8rWfNjfCfZ9k2W7H_PtPf5TVYBfdIJXpNLLQnqFIkBZ0jGSTsxp5gRKEYglWoXa00Na2Y4y2rqksDRiRlkM1KkQYdlH7HEI44qUItSXr7-jbeBknT-ieoSq3dn_7CPn2AzF2VHsKnrGplz5nN1tV2UxaimPB0ce-lXJ3U28cO1g57yJ-hawdVq7mNtsgCQvagJhyCsIcIkwwBrXQMOnUwOf4aiEw3ENAY5gMJ5x28BbUg7jZ1XbOIj9Erat3Ts4yaO6HoTdasfLb0AuSVNQKJ18e8Hyh9iKeTZdVqVbYCBUptEbY1NtJXrRTbVXBmWaWKcSaV-ylYlVhzRo2ofzRzP8ZdO_3c8yHUhkohf_8f4r9nQvP-wNe_v9gyU2Q8L3sWhtfZlNX9WtW2FPiuur86ZejX4JbPjALvIDk54jAA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Conclusion+Of+Non-exclusive+Discount+Agreements+According+To+130a+Para.+8+Sgb+V+On+Medicinal+Products+%28open-house+Procedure%29+%5BTender+documents+%3A+T487403780%5D&rft.jtitle=MENA+Report&rft.date=2023-06-06&rft.pub=Disco+Digital+Media%2C+Inc&rft.eissn=2219-0112